Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.3390/ cancers14133106

Título: Implication of hepsin from primary tumor in the prognosis of colorectal cancer patients
Fecha de publicación: 24-jun-2022
Editorial: MDPI
Cita bibliográfica: Cancers 2022, 14, 3106
ISSN: Electronic: 2072-6694
Palabras clave: Hepsin
Colorectal cancer
Thrombosis
Metastasis
Hepsin paradox
Resumen: Hepsin is a type II transmembrane serine protease whose deregulation promotes tumor invasion by proteolysis of the pericellular components. In colorectal cancer, the implication of hepsin is unknown. Consequently, we aimed to study the correlations between hepsin expression and different clinical-histopathological variables in 169 patients with localized colorectal cancer and 118 with metastases. Tissue microarrays were produced from samples at diagnosis of primary tumors and stained with an anti-hepsin antibody. Hepsin expression was correlated with clinical histopathological variables by using the chi-square and Kruskal–Wallis tests, Kaplan–Meier and Aalen–Johansen estimators, and Cox and Fine and Gray multivariate models. In localized cancer patients, high-intensity hepsin staining was associated with reduced 5-year disease-free survival (p-value = 0.16). Medium and high intensity of hepsin expression versus low expression was asso ciated with an increased risk of metastatic relapse (hazard ratio 2.83, p-value = 0.035 and hazard ratio 3.30, p-value = 0.012, respectively), being a better prognostic factor than classic histological variables. Additionally, in patients with localized tumor, 5-year thrombosis cumulative incidence increased with the increment of hepsin expression (p-value = 0.038). Medium and high intensities of hepsin with respect to low intensity were associated with an increase in thrombotic risk (hazard ratio 7.71, p-value = 0.043 and hazard ratio 9.02, p-value = 0.028, respectively). This relationship was independent of previous tumor relapse (p-value = 0.036). Among metastatic patients, low hepsin expression was associated with a low degree of tumor differentiation (p-value < 0.001) and with major metastatic dissemination (p-value = 0.023). Hepsin is a potential thrombotic and metastatic biomarker in patients with localized colorectal cancer. In metastatic patients, hepsin behaves in a paradoxical waywith respect to differentiation and invasion processes.
Autor/es principal/es: Zaragoza-Huesca, David
Nieto-Olivares, Andrés
García-Molina, Francisco
Ricote, Guillermo
Montenegro, Sofía
Sánchez-Cánovas, Manuel
Garrido-Rodríguez, Pedro
Peñas-Martínez, Julia
Vicente, Vicente
Martínez Díaz, Francisco
Lozano, María Luisa
Carmona-Bayona, Alberto
Martínez-Martínez, Irene
Versión del editor: https://www.mdpi.com/2072-6694/14/13/3106
URI: http://hdl.handle.net/10201/147362
DOI: https://doi.org/10.3390/ cancers14133106
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 16
Derechos: info:eu-repo/semantics/openAccess
Atribución 4.0 Internacional
Descripción: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/. This document is the Published version of a Published Work that appeared in final form in Cancers. To access the final edited and published work see https://doi.org/10.3390/ cancers14133106
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
cancers-14-03106-v2.pdf1,26 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons